These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 25109336)

  • 1. GD3 synthase regulates epithelial-mesenchymal transition and metastasis in breast cancer.
    Sarkar TR; Battula VL; Werden SJ; Vijay GV; Ramirez-Peña EQ; Taube JH; Chang JT; Miura N; Porter W; Sphyris N; Andreeff M; Mani SA
    Oncogene; 2015 Jun; 34(23):2958-67. PubMed ID: 25109336
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation of serine 367 of FOXC2 by p38 regulates ZEB1 and breast cancer metastasis, without impacting primary tumor growth.
    Werden SJ; Sphyris N; Sarkar TR; Paranjape AN; LaBaff AM; Taube JH; Hollier BG; Ramirez-Peña EQ; Soundararajan R; den Hollander P; Powell E; Echeverria GV; Miura N; Chang JT; Piwnica-Worms H; Rosen JM; Mani SA
    Oncogene; 2016 Nov; 35(46):5977-5988. PubMed ID: 27292262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disialyl GD2 ganglioside suppresses ICAM-1-mediated invasiveness in human breast cancer MDA-MB231 cells.
    Kwon KM; Chung TW; Kwak CH; Choi HJ; Kim KW; Ha SH; Cho SH; Lee YC; Ha KT; Lee MJ; Kim CH
    Int J Biol Sci; 2017; 13(3):265-275. PubMed ID: 28367091
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ganglioside GD2 identifies breast cancer stem cells and promotes tumorigenesis.
    Battula VL; Shi Y; Evans KW; Wang RY; Spaeth EL; Jacamo RO; Guerra R; Sahin AA; Marini FC; Hortobagyi G; Mani SA; Andreeff M
    J Clin Invest; 2012 Jun; 122(6):2066-78. PubMed ID: 22585577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of glycosphingolipids GD3 and GD2 with growth factor receptors maintains breast cancer stem cell phenotype.
    Liang YJ; Wang CY; Wang IA; Chen YW; Li LT; Lin CY; Ho MY; Chou TL; Wang YH; Chiou SP; Lin YJ; Yu J
    Oncotarget; 2017 Jul; 8(29):47454-47473. PubMed ID: 28537895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Triptolide suppresses the growth and metastasis of non-small cell lung cancer by inhibiting β-catenin-mediated epithelial-mesenchymal transition.
    Deng QD; Lei XP; Zhong YH; Chen MS; Ke YY; Li Z; Chen J; Huang LJ; Zhang Y; Liang L; Lin ZX; Liu Q; Li SP; Yu XY
    Acta Pharmacol Sin; 2021 Sep; 42(9):1486-1497. PubMed ID: 33893396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The ganglioside G(D2) induces the constitutive activation of c-Met in MDA-MB-231 breast cancer cells expressing the G(D3) synthase.
    Cazet A; Bobowski M; Rombouts Y; Lefebvre J; Steenackers A; Popa I; Guérardel Y; Le Bourhis X; Tulasne D; Delannoy P
    Glycobiology; 2012 Jun; 22(6):806-16. PubMed ID: 22301273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IKK inhibition by BMS-345541 suppresses breast tumorigenesis and metastases by targeting GD2+ cancer stem cells.
    Battula VL; Nguyen K; Sun J; Pitner MK; Yuan B; Bartholomeusz C; Hail N; Andreeff M
    Oncotarget; 2017 Jun; 8(23):36936-36949. PubMed ID: 28415808
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FOXC2 expression links epithelial-mesenchymal transition and stem cell properties in breast cancer.
    Hollier BG; Tinnirello AA; Werden SJ; Evans KW; Taube JH; Sarkar TR; Sphyris N; Shariati M; Kumar SV; Battula VL; Herschkowitz JI; Guerra R; Chang JT; Miura N; Rosen JM; Mani SA
    Cancer Res; 2013 Mar; 73(6):1981-92. PubMed ID: 23378344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EMT-related protein expression in polyploid giant cancer cells and their daughter cells with different passages after triptolide treatment.
    Wang X; Zheng M; Fei F; Li C; Du J; Liu K; Li Y; Zhang S
    Med Oncol; 2019 Aug; 36(9):82. PubMed ID: 31407170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-300 inhibits epithelial to mesenchymal transition and metastasis by targeting Twist in human epithelial cancer.
    Yu J; Xie F; Bao X; Chen W; Xu Q
    Mol Cancer; 2014 May; 13():121. PubMed ID: 24885626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fucoidan induces changes in the epithelial to mesenchymal transition and decreases metastasis by enhancing ubiquitin-dependent TGFβ receptor degradation in breast cancer.
    Hsu HY; Lin TY; Hwang PA; Tseng LM; Chen RH; Tsao SM; Hsu J
    Carcinogenesis; 2013 Apr; 34(4):874-84. PubMed ID: 23275155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gemifloxacin inhibits migration and invasion and induces mesenchymal-epithelial transition in human breast adenocarcinoma cells.
    Chen TC; Hsu YL; Tsai YC; Chang YW; Kuo PL; Chen YH
    J Mol Med (Berl); 2014 Jan; 92(1):53-64. PubMed ID: 24005829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triptolide Attenuates Renal Tubular Epithelial-mesenchymal Transition Via the MiR-188-5p-mediated PI3K/AKT Pathway in Diabetic Kidney Disease.
    Xue M; Cheng Y; Han F; Chang Y; Yang Y; Li X; Chen L; Lu Y; Sun B; Chen L
    Int J Biol Sci; 2018; 14(11):1545-1557. PubMed ID: 30263007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triptolide inhibits CD133
    Acikgoz E; Tatar C; Oktem G
    J Cell Biochem; 2020 Jun; 121(5-6):3313-3324. PubMed ID: 31904143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GD2 and its biosynthetic enzyme GD3 synthase promote tumorigenesis in prostate cancer by regulating cancer stem cell behavior.
    Bhat AM; Mohapatra BC; Luan H; Mushtaq I; Chakraborty S; Kumar S; Wu W; Nolan B; Dutta S; Storck MD; Schott M; Meza JL; Lele SM; Lin MF; Cook LM; Corey E; Morrissey C; Coulter DW; Rowley MJ; Natarajan A; Datta K; Band V; Band H
    Sci Rep; 2024 Jun; 14(1):13523. PubMed ID: 38866755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hard antler extract inhibits invasion and epithelial-mesenchymal transition of triple-negative and Her-2
    Xu G; Zhao H; Xu J; Zhang Y; Qi X; Shi A
    J Ethnopharmacol; 2021 Apr; 269():113705. PubMed ID: 33346025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TNF differentially regulates ganglioside biosynthesis and expression in breast cancer cell lines.
    Dewald JH; Cavdarli S; Steenackers A; Delannoy CP; Mortuaire M; Spriet C; Noël M; Groux-Degroote S; Delannoy P
    PLoS One; 2018; 13(4):e0196369. PubMed ID: 29698439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 13
    Souid S; Elsayed HE; Ebrahim HY; Mohyeldin MM; Siddique AB; Karoui H; El Sayed KA; Essafi-Benkhadir K
    Mol Carcinog; 2018 Nov; 57(11):1507-1524. PubMed ID: 29978911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FOXF2 suppresses the FOXC2-mediated epithelial-mesenchymal transition and multidrug resistance of basal-like breast cancer.
    Cai J; Tian AX; Wang QS; Kong PZ; Du X; Li XQ; Feng YM
    Cancer Lett; 2015 Oct; 367(2):129-37. PubMed ID: 26210254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.